Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06792539 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty
A NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip, sponsored by JointMedica.
- Recruiting
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 10
- Study locations
NCT06792539: Recruiting NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip, sponsored by JointMedica.
NCT06792539 is a NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip that is actively recruiting participants, run by JointMedica. The registered enrollment target is 238 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06792539, a NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip, is actively recruiting participants, sponsored by JointMedica.
- RECRUITING
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
Primary Outcome
The proportion of Polymotion subjects achieving Month-24 composite clinical success (CCS) will be compared to a propensity-score matched total hip arthroplasty control group collected from Rush University Medical Center, with the goal of demonstrating non-inferiority. Composite clinical success will be analyzed via Harris Hip Scores measuring pain, activity, and function, absence of device subsidence, progressive radiolucencies, osteolysis or migration through radiographic assessment, and the a
Conditions Studied
Interventions
- DEVICE Polymotion Hip Resurfacing (PHR) System
Study Locations (10)
Florida
- Florida Medical Clinic Orlando Health - Tampa
Illinois
- Rush University Medical Center - Chicago
Maryland
- Sinai Hospital / LifeBridge Health - Baltimore
New York
- NYU Longone - New York
Ohio
- Joint Implant Surgeons - New Albany
Oregon
- Oregon Health & Science University - Portland
South Carolina
- Midlands Orthopaedics & Neurosurgery - Columbia
Virginia
- Hampton Road Orthopaedics - Newport News
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2025-01-22 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT06792539 shows while recruiting
NCT06792539 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Degenerative Joint Disease of Hip appearing as the primary indexed condition, and to 1 intervention - of which Polymotion Hip Resurfacing (PHR) System is the first listed.
NCT06792539 lists 10 locations in 10 states (Florida, Illinois, Maryland).
Frequently Asked Questions
What is clinical trial NCT06792539 about?
NCT06792539 is a clinical study titled "Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty". The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis,...
What is the current status of trial NCT06792539?
This trial is currently recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2025-01-22. Estimated completion is 2028-01.
What conditions does trial NCT06792539 study?
This clinical trial studies the following conditions: Degenerative Joint Disease of Hip, Dysplasia; Hip, Osteoarthritis of the Hip.
What interventions are being tested in trial NCT06792539?
The interventions under investigation include: Polymotion Hip Resurfacing (PHR) System (DEVICE).
Who is sponsoring clinical trial NCT06792539?
This trial is sponsored by JointMedica, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06792539 being conducted?
This trial has 10 study locations across Florida, Illinois, Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Joint Disease of Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06792539's enrollment target sits among peer trials
238 459th of 2000 higher than 1,541 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI